- Home
- CLPS vs INKT Comparison
CLPS vs INKT Comparison
Compare CLPS & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- INKT
- Stock Information
- Founded
- CLPS 2005
- INKT 2017
- Country
- CLPS Hong Kong
- INKT United States
- Employees
- CLPS N/A
- INKT N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- INKT Medicinal Chemicals and Botanical Products
- Sector
- CLPS Technology
- INKT Health Care
- Exchange
- CLPS Nasdaq
- INKT Nasdaq
- Market Cap
- CLPS 32.7M
- INKT 33.6M
- IPO Year
- CLPS 2018
- INKT 2021
- Fundamental
- Price
- CLPS $1.02
- INKT $7.25
- Analyst Decision
- CLPS
- INKT Strong Buy
- Analyst Count
- CLPS 0
- INKT 2
- Target Price
- CLPS N/A
- INKT $37.50
- AVG Volume (30 Days)
- CLPS 14.3K
- INKT 5.5K
- Earning Date
- CLPS 03-05-2025
- INKT 05-13-2025
- Dividend Yield
- CLPS 12.74%
- INKT N/A
- EPS Growth
- CLPS N/A
- INKT N/A
- EPS
- CLPS N/A
- INKT N/A
- Revenue
- CLPS $153,816,045.00
- INKT N/A
- Revenue This Year
- CLPS N/A
- INKT N/A
- Revenue Next Year
- CLPS N/A
- INKT N/A
- P/E Ratio
- CLPS N/A
- INKT N/A
- Revenue Growth
- CLPS 5.81
- INKT N/A
- 52 Week Low
- CLPS $0.68
- INKT $4.56
- 52 Week High
- CLPS $1.70
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- CLPS 43.61
- INKT 39.62
- Support Level
- CLPS $0.95
- INKT $7.23
- Resistance Level
- CLPS $1.11
- INKT $8.59
- Average True Range (ATR)
- CLPS 0.09
- INKT 0.72
- MACD
- CLPS -0.01
- INKT -0.10
- Stochastic Oscillator
- CLPS 30.61
- INKT 0.66
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.